Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancer
- 29 August 2024
- journal article
- review article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 263, 155569
Abstract
No abstract availableKeywords
This publication has 193 references indexed in Scilit:
- Hsa_circ_0002082 up‐regulates Centromere Protein F via abolishing miR‐508‐3p to promote breast cancer progressionJournal of Clinical Laboratory Analysis, 2022
- Circ_0001667 knockdown blocks cancer progression and attenuates adriamycin resistance by depleting NCOA3 via releasing miR‐4458 in breast cancerDrug Development Research, 2021
- Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR‐140‐3p/SKA2 axisMolecular Oncology, 2020
- Identification of plasma hsa_circ_0008673 expression as a potential biomarker and tumor regulator of breast cancerJournal of Clinical Laboratory Analysis, 2020
- Circular RNA La‐related RNA‐binding protein 4 correlates with reduced tumor stage, as well as better prognosis, and promotes chemosensitivity to doxorubicin in breast cancerJournal of Clinical Laboratory Analysis, 2020
- Circular RNA VRK1 correlates with favourable prognosis, inhibits cell proliferation but promotes apoptosis in breast cancerJournal of Clinical Laboratory Analysis, 2020
- Profiling and integrated analysis of differentially expressed circRNAs as novel biomarkers for breast cancerJournal of Cellular Physiology, 2020
- Circular RNA circ_0103552 forecasts dismal prognosis and promotes breast cancer cell proliferation and invasion by sponging miR‐1236Journal of Cellular Biochemistry, 2019
- Breast Cancer TreatmentJAMA, 2019
- MORC4 is a novel breast cancer oncogene regulated by miR‐193b‐3pJournal of Cellular Biochemistry, 2018